Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

8-OH-PBZI

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
8-OH-PBZI
Clinical data
ATC code
  • none
Identifiers
  • (3aS,9bR)-3-propyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-8-ol
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC15H21NO
Molar mass231.339 g·mol−1
3D model (JSmol)
  • CCCN1CC[C@H]2[C@@H]1CCC3=C2C=C(C=C3)O
  • InChI=1S/C15H21NO/c1-2-8-16-9-7-13-14-10-12(17)5-3-11(14)4-6-15(13)16/h3,5,10,13,15,17H,2,4,6-9H2,1H3/t13-,15+/m1/s1 checkY
  • Key:LJDRQPOQHHOXHM-HIFRSBDPSA-N checkY
  (verify)

8-OH-PBZI is a drug used in scientific research which acts as a potent and selectiveagonist for thedopamineD3receptor.[1][2][3]

References

[edit]
  1. ^Scheideler MA, Martin J, Hohlweg R, Rasmussen JS, Naerum L, Ludvigsen TS, et al. (November 1997). "The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain".European Journal of Pharmacology.339 (2–3):261–70.doi:10.1016/S0014-2999(97)01372-1.PMID 9473144.
  2. ^Fink-Jensen A, Nielsen EB, Hansen L, Scheideler MA (January 1998). "Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI".European Journal of Pharmacology.342 (2–3):153–61.doi:10.1016/S0014-2999(97)01494-5.PMID 9548380.
  3. ^Malik P, Andersen MB, Peacock L (August 2004). "The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia".Pharmacology, Biochemistry, and Behavior.78 (4):805–10.doi:10.1016/j.pbb.2004.05.019.PMID 15301939.S2CID 19410897.
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=8-OH-PBZI&oldid=1269659583"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp